Skip to content

Benefits of supplemental oxygen on exercise capacity and dyspnea in IPF patients

Benefits of supplemental oxygen on exercise capacity and dyspnea in IPF patients - Benefits of supplemental oxygen on exercise capacity and dyspnea in IPF patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025256
Enrollment
106
Registered
2016-12-13
Start date
2009-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopathic pulmonary fibrosis

Interventions

oxygen gas air gas

Sponsors

Tosei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (i) diagnosis of IPF (ii) shortness of breath on effort (iii) stable clinical condition with no infection or exacerbation in the previous three months.

Exclusion criteria

Exclusion criteria: severe comorbid illnesses, collagen vascular diseases, and the need for long-term oxygen therapy.

Design outcomes

Primary

MeasureTime frame
endurance time of constant work-rate test

Secondary

MeasureTime frame
dyspnea, leg fatigue (Borg scale) (before and every 1 minute and end of oxygen therapy)

Countries

Japan

Contacts

Public ContactShinichi Arizono

Seirei Christopher University, School of Health Sciences

arizono-s@umin.ac.jp053-439-1400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026